DOP2015000155A - Composición farmacéutica oftalmológica tópica que contiene regorafenib - Google Patents

Composición farmacéutica oftalmológica tópica que contiene regorafenib

Info

Publication number
DOP2015000155A
DOP2015000155A DO2015000155A DO2015000155A DOP2015000155A DO P2015000155 A DOP2015000155 A DO P2015000155A DO 2015000155 A DO2015000155 A DO 2015000155A DO 2015000155 A DO2015000155 A DO 2015000155A DO P2015000155 A DOP2015000155 A DO P2015000155A
Authority
DO
Dominican Republic
Prior art keywords
typical
pharmaceutical composition
composition containing
ophthalmological pharmaceutical
containing regorafenib
Prior art date
Application number
DO2015000155A
Other languages
English (en)
Inventor
Georges Von Degenfeld
Joerg Keldenich
Michael Bottger
Julia Freundlieb
Uwe Muenster
Andreas Ohm
Annett Richter
Bernd Riedl
Claudia Hirth-Dietrich
Jürgen Klar
Original Assignee
Bayer Healthcare Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Llc filed Critical Bayer Healthcare Llc
Publication of DOP2015000155A publication Critical patent/DOP2015000155A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A COMPOSICIONES FARMACÉUTICAS OFTALMOLÓGICAS TÓPICAS QUE CONTIENEN REGORAFENIB, UN HIDRATO, SOLVATO, O SAL ACEPTABLE DESDE EL PUNTO DE VISTA FARMACÉUTICO DEL MISMO O UN POLIMORFO DEL MISMO PERO SIN SÍLICE HIDRÓFOBA Y SU PROCEDIMIENTO DE PREPARACIÓN Y SU USO PARA TRATAR TRASTORNOS OFTALMOLÓGICOS.
DO2015000155A 2012-12-21 2015-06-17 Composición farmacéutica oftalmológica tópica que contiene regorafenib DOP2015000155A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12198892 2012-12-21

Publications (1)

Publication Number Publication Date
DOP2015000155A true DOP2015000155A (es) 2015-08-31

Family

ID=47458742

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2015000155A DOP2015000155A (es) 2012-12-21 2015-06-17 Composición farmacéutica oftalmológica tópica que contiene regorafenib

Country Status (27)

Country Link
US (2) US20140179745A1 (es)
EP (1) EP2934481A1 (es)
JP (1) JP2016507505A (es)
KR (1) KR20150100670A (es)
CN (1) CN104955443A (es)
AP (1) AP2015008493A0 (es)
AR (1) AR094104A1 (es)
AU (1) AU2013364004A1 (es)
BR (1) BR112015014078A2 (es)
CA (1) CA2895804A1 (es)
CL (1) CL2015001701A1 (es)
CR (1) CR20150327A (es)
CU (1) CU20150063A7 (es)
DO (1) DOP2015000155A (es)
EA (1) EA201500669A1 (es)
EC (1) ECSP15026386A (es)
IL (1) IL238791A0 (es)
MA (1) MA38215A1 (es)
MX (1) MX2015007488A (es)
PE (1) PE20151784A1 (es)
PH (1) PH12015501407A1 (es)
SG (1) SG11201503838WA (es)
TN (1) TN2015000280A1 (es)
TW (1) TW201431568A (es)
UY (1) UY35183A (es)
WO (1) WO2014100797A1 (es)
ZA (1) ZA201505196B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3458031A4 (en) * 2016-05-16 2020-01-22 Delivra Inc. TRANSDERMAL FORMULATIONS FOR THE DELIVERY OF CELECOXIB AND THEIR USE IN THE TREATMENT OF CELCOXIB-SENSITIVE DISEASES AND CONDITIONS
CN112834485B (zh) * 2021-02-07 2022-03-29 西南交通大学 激光诱导击穿光谱元素定量分析的一种非定标方法
KR102413226B1 (ko) 2021-08-26 2022-06-23 충북대학교 산학협력단 레고라페닙을 유효성분으로 포함하는 항노화 조성물
KR20230166353A (ko) 2022-05-30 2023-12-07 (주) 레비레스코 감태 추출물, 귤피 추출물, 및 녹차 추출물을 유효성분으로 포함하는 자외선에 대한 세포 보호용 또는 mmp-1 발현 억제용 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ580384A (en) * 2003-07-23 2011-03-31 Bayer Pharmaceuticals Corp 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide and metabolites for the treatment and prevention of diseases and conditions
PL1885336T3 (pl) 2005-05-10 2009-08-31 Alcon Inc Kompozycja w postaci zawiesiny zawierająca substancję aktywną, poloksamerowy lub meroksapolowy surfaktant i glikol oraz zastosowanie kompozycji do wytwarzania leku do leczenia chorób oczu
EP1893216A4 (en) 2005-06-08 2012-08-08 Targegen Inc METHOD AND COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES
US20080293691A1 (en) 2005-11-29 2008-11-27 Smithkline Beecham Corporation Treatment Method
EP1962828A1 (en) * 2005-12-15 2008-09-03 Bayer HealthCare AG Diaryl urea for treating inflammatory skin, eye and/or ear diseases
WO2007076358A1 (en) 2005-12-23 2007-07-05 Alcon, Inc. PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
WO2008027341A2 (en) 2006-08-30 2008-03-06 Merck & Co., Inc. Topical ophthalmic formulations
AR062927A1 (es) 2006-10-11 2008-12-17 Bayer Healthcare Ag 4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
EP3165606A1 (en) 2009-05-01 2017-05-10 Ophthotech Corporation Methods for treating or preventing ophthalmological diseases
CN102573477A (zh) 2009-07-16 2012-07-11 葛兰素惠尔康制造业私人有限公司 治疗方法
JP5998213B2 (ja) * 2011-06-28 2016-09-28 バイエル・ヘルスケア・エルエルシーＢａｙｅｒ ＨｅａｌｔｈＣａｒｅ ＬＬＣ レゴラフェニブを含有する眼科用局所医薬組成物

Also Published As

Publication number Publication date
JP2016507505A (ja) 2016-03-10
US20150328145A1 (en) 2015-11-19
EA201500669A1 (ru) 2015-12-30
CL2015001701A1 (es) 2015-10-16
MX2015007488A (es) 2015-09-04
AP2015008493A0 (en) 2015-05-31
IL238791A0 (en) 2015-06-30
AU2013364004A1 (en) 2015-06-04
AR094104A1 (es) 2015-07-08
WO2014100797A1 (en) 2014-06-26
MA38215A1 (fr) 2017-01-31
CR20150327A (es) 2015-09-14
TW201431568A (zh) 2014-08-16
PH12015501407A1 (en) 2015-09-07
ZA201505196B (en) 2017-11-29
CA2895804A1 (en) 2014-06-26
UY35183A (es) 2014-07-31
SG11201503838WA (en) 2015-07-30
TN2015000280A1 (en) 2016-10-03
ECSP15026386A (es) 2016-01-29
BR112015014078A2 (pt) 2018-05-15
CU20150063A7 (es) 2015-11-27
KR20150100670A (ko) 2015-09-02
PE20151784A1 (es) 2015-11-25
EP2934481A1 (en) 2015-10-28
CN104955443A (zh) 2015-09-30
US20140179745A1 (en) 2014-06-26

Similar Documents

Publication Publication Date Title
GT201500053A (es) Composicion farmaceutica recubierta que contiene regorafenib
CL2018000318A1 (es) Compuestos derivados de piridinona, inhibidores de bromodominio; composición farmacéutica que los comprende; y su uso en el tratamiento de enfermedades del cáncer. (solicitud divisional 201600925)
CY1118379T1 (el) Αναστολεις ιου ηπατιτιδας c
GT201300322A (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib
CU20160052A7 (es) Amino-heteroaril-benzamidas como inhibidores de cinasa
CL2012002944A1 (es) Compuestos derivados de amino-pirimidinas; composiciones farmacéuticas que los comprenden; y su uso para el tratamiento de una enfermedad afección seleccionada de trastornos neuromusculares, esclerosis lateral amiotrófica, miastenia grave, entre otras.
CL2012002945A1 (es) Compuestos derivados de amino-piridazinas; composiciones farmacéuticas que los comprenden; y su uso para el tratamiento de una enfermedad afección seleccionada de trastornos neuromusculares, esclerosis lateral amiotrófica, miastenia grave, entre otras.
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
BR112015022191A2 (pt) compostos heteroarila, seu uso e composição que os compreende
CO6690768A2 (es) Derivados de triazina-oxadiazoles, útiles como inhibidores de los canales de sodio navi.7
EA201301240A1 (ru) Полиморфная форма бензоата линаглиптина
AR090456A1 (es) Combinaciones farmaceuticas que comprenden un analogo de tionucleotidos
EA201500365A1 (ru) Комбинация регорафениба и ацетилсалициловой кислоты для лечения рака
BR112012018955A2 (pt) combinação para administração simultânea, separada ou sequencial e ligante sigma ou um sal, isômero, pró-droga ou solvato farmaceuticamente aceitável do mesmo
BR112015011430A2 (pt) composição para liberação imediata e prolongada
UY37837A (es) Nuevos compuestos heterocíclicos como inhibidores de cdk8/19
UY33530A (es) Composiciones farmacéuticas para el tratamiento de enfermedades respiratorias e inflamatorias
DOP2018000066A (es) Compuestos útiles para inhibir ror-gamma-t
BR112016024235A2 (pt) composições farmacêuticas compreendendo agentes antibacterianos
DOP2015000155A (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib
UY35209A (es) Compuestos tricíclicos
EA201591177A1 (ru) Трициклические соединения для ингибирования канала cftr
PE20150167A1 (es) (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel
AR090073A1 (es) N-etil-n-fenil-1,2-dihidro-4,5-di-hidroxi-1-metil-2-oxo-3-quinolinacarboxamida, su preparacion y usos
BR112014009760A2 (pt) análogos de ácido siálico, seu uso e composição farmacêutica e composição farmacêutica de liberação sustentada os compreendendo